Red Cell Indices and Functions Differentiating Patients with the β-Thalassaemia Trait from those with Iron Deficiency Anaemia

Author： Okan V   Cigiloglu A   Cifci S   Yilmaz M   Pehlivan M  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.1, 2009-01, pp. : 25-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US: A Literature Review

By Zhang Bin  

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 461-474

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia: Impact of Splenectomy and Iron Status

By >  

Clinical Pharmacokinetics, Vol. 50, Iss. 1, 2011-01 ,pp. : 41-50

Adis International

Access to resources Recommend Favorite

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

By  

International Journal Of Pharmacy Practice, Vol. 26, Iss. 1, 2018-02 ,pp. : 55-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carbimazole: Iron deficiency anaemia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1390, 2012-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Ferric carboxymaltose: a guide to its use in iron-deficiency anaemia

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite